Movement Disorders Drugs

Random Miscellaneous Quiz

Can you name the Movement Disorders Drugs?

Quiz not verified by Sporcle

 plays        
How to Play
HintAnswer
SE: HA, nasal congestion, increased arousal, pulmonary infiltrates, ergoline-induced s/s, erythromelagia, vasospasm, & pleural or retroperitoneal fibroses.
Olanzapine class
P-kinetics: Only helpful for Huntington's dz chorea at very high doses
Contraindications: psychotic pts, angle closure glaucoma (Increased IOP), active peptic ulcers, hx of melanoma (melanin precursor)
MOA: Dopamine precursor able to cross the BBB where it is decarboxylated by dopa decarboxylase to form dopamine.
SE: Ergoline-induced toxicity effects unlikely. Postural hypotension, fatigue, somnolence, peripheral edema, nausea, constipation, dyskinesias, & confusion.
Apomorphine class
Clonazepam class
Tetrabenxine class
Clonidine class
Use: Reduced response to fluctuations w/ L-dopa. Decreased L-dopa clearance. Decreased dopa decarboxylase --> compensatory increase in COMT.
Levodopa class
Use: Enhance & prolong the effects of L-dopa; reduce response fluctuations; lowers necessary dose of L-dopa. ?Antioxidant properties?
MOA: Pure D2 receptor agonist
Selegiline class
Pramipexole class
Entacapone class
Use: Temporary relief of off-period akinesia in Parkinsons. Also used to tx ED.
MOA: D2 receptor agonist (partial D1 agonist)
SE: Insomnia when taken late in the day
P-kinetics: Given PO. Loses effectiveness over time.
Bromocriptine class
Use: May improve tremor & rigidity in Parkinsons. Little effect on bradykinesia.
Use: Increases amount of L-dopa able to cross the BBB. Combo with L-dopa allows for L-dopa dose reduction up to 85%.
SE: GI (L-dopa alone): anorexia, n/v (avoid anti-emetics like phenothiazines d/t their extrapyramidal effects -- dopamine antagonist; carbidopa reduces these effects.
Quetiapine class
Biperiden class
SE: Asthenia, dizziness, GI disorders, & elevation of liver enzymes.
Use: depression associated with Huntington's disease
SE: Mental Disturbances: confusion, hallucinations, delusions, other psychiatric reactions.
MOA: Central (brain) anti-cholinergic
MOA: Prevents the metabolism of L-dopa --> 3-O-methyldopa (3OMD) by Catechol-0-methyltransferase
HintAnswer
Haloperidol class
SE: Nausea (pretreat w/ anti-emetic - trimethobenzamide or domiperidone), dyskinesias, drowsiness, sweating, hypotension
Trihexyphenidyl class
Tolcapone class
Use: prolong ALS survival by months
Use: Can be used as 1st line tx for Parkinson's dz - often in combo w/ Sinemet. Commonly used to tx hyperprolactinemia.
P-kinetics: Similar to Pramipexole
Benzotropine class
SE: Dyskinesias: chorea, ballismus, athetosis, dystonia, myoclonus, tics, tremors. Behavioral effects: anxiety/ agitation, insomnia/ somnolence, confusion/ delusions/ hallucination
Amantadine class
SE: If adverse effects become too severe withdraw gradually. break for 3-21 days, and reinstate gradually
Use: Similar to Pramipexole
P-kinetics: Note: Antidepressant MAOIs are either nonspecific or inhibit MAO-A more specifically (5-HT & NE)
Fluphenzaine class
P-kinetics: Rapid PO absorption, excreted unchanged in urine, gradually increase dose
SSRI class
MOA: Not completely known. Inhib effects on glutamate-R, NMDA antag, Inactivation of voltage gated Na+ channels. Interferes w/ intracellular events post excitatory AA-R activation
SE: May interfere with uptake - Rx metabolizes L-dopa into 3-methyldopa which competes for active transport across the BBB.
P-kinetics: Only 1-3% enters the brain across BBB unaltered. Peak plasma levels 1-2 hrs post PO dose. Plasma t1/2 = 1-2 hrs (pts vary -- dosing 3-4x/day).
Use: Huntington's dz pts w/ psychosis or disruptive behavior. Also helpful w/ chorea
Pergolide class
SE: Other: dry mouth, blurred vision, mydriasis, urinary retention, n/v, constipation, tachycardia, increased IOP.
Interactions: Should not be taken w/ meperidine, TCAs, serotonin reuptake inhibitors, or in combo w/ nonspecific MAOIs
P-kinetics: Start with a small dose
P-kinetics: Response can decline over time or stop completely. Start at small dose & escalate as effects diminish. Wearing off rxs. Toxicity concern is supersensitivity develpmnt -
Use: Most effective drug in tx of Tourette's
P-kinetics: Readily absorbed from intestines (depends on rate of gastric emptying and pH -- delayed by food). Some other AAs can compete for transport across the BBB.
Reserpine class
Carbidopa class
Orphenadrine class
P-kinetics: Variable absorption from GI, peak plasma levels 1-2 hrs post PO dose. Excreted in bile & feces. Build up dose slowly over 2-3 mo to avoid adverse effects
Contraindications: Prostatic hyperplasia, obstructive GI dz, & angle-closure glaucoma
HintAnswer
Use: Monotherapy for mild Parkinsonism or combo tx for advanced pts. Reduces L-dopa dose & smooths response fluctuations. Putative neuroprotective effects (scavenges free radicals)
SE: GI: anorexia, n/v, constipation, dyspepsia, peptic ulcers, symptoms of reflux esophagitis. CV: postural hypotension & cardiac arrhythmias. Dyskinesias.
Use: alleviation of chorea if refractory to atypical
P-kinetics: Start at low dose & gradually increase
MOA: D1 and D2 receptor agonist
Rasagiline class
P-kinetics: 2/3 appears in urine as metabolites within 8 hrs (homovanillic acid - HVA and dihydrocyphenylacetic acid - DOPAC). Best response is in the first few yrs of tx.
Carbamazepine class
Use: alleviation of chorea
SE: May be hepatotoxic - (needs signed pt consent & liver monitoring Q 2 wks x 1 yr)
P-kinetics: SQ. Rapid onset ~ 10 min. Duration 2 hrs
Ropinirole class
Use: Similar to Bromocriptine, but more effective. May benefit pts not receiving L-dopa. Aids pt w/ response fluctuations to L-dopa
Riluzole class
MOA: Increases dopamine release & reduces dopamine reuptake into dopaminergic nerve terminals of substantia nigra neurons. Unknown MOA.
SE: Increased L-dopa toxicity (dyskinesias, nausea, & confusion), diarrhea, abd pain, orthostatic hypotension, sleep disturbances, & orange urine.
MOA: Inhibits the L-dopa --> dopamine conversion by dopa decarboxylase in the periphery (does not cross BBB).
Contraindications: psychotic illness, MI hx, PVD, peptic ulcers
Group P-kinetics: Advantages: No enzymatic conversion required, crosses BBB w/o competing for amino acid transporter. No potentially toxic metabolites
MOA: Somewhat selective MAO-B inhibitors. Retard the breakdown of dopamine
MOA: Preferential affinity for D3 family of receptors
SE: CV: Increased HR, PVCs, A fib (rare), postural hypotension, HTN (usually in the presence of non-specific MAOI or with large doses).
Butyrophenones class
Carbidopa + levidopa (1:10 or 1:4)
SE: CNS: drowsiness, mental slowness, inattention, restless, confusion, agitation, delusions, hallucinations, & mood changes.
Interactions: Vitamin B6 enhances the extracerebral metabolism of L-dopa. MAOI w/ L-dopa can --> HTNive crisis if given within 2 weeks of each other.
P-kinetics: Well absorbed orally. T1/2 ~ 12 hrs. Hepatic metabolism (cytochrome P450, CYP1A2) -- caution in pts w/ hepatic insufficiency.
TCA class
Phenothiazine class
Use: Gold standard in Parkinson's dz - most efficacious treatment
Procyclidine class
Risperidone class

Friend Scores


  Player Best Score Plays Last Played
You You haven't played this game yet.

You Might Also Like...

Extras

Created Oct 8, 2011ReportNominate
Tags:disorder, drug, movement